Showing results (1-10 of 9,760) with videos related to
Sort By:
Pageof 976
FEMS Microbiology Letters|February 1, 1990
Hyperproduction of TEM-1 beta-lactamase in clinical isolates of Escherichia coli serotype O15K Shannon, H Williams, A King, et al.The Journal of Antimicrobial Chemotherapy|November 1, 1992
Prevalence of resistance to beta-lactam antibiotics in Escherichia coli isolated from blood from 1969-1991K Shannon, A King, I PhillipsThe Journal of Antimicrobial Chemotherapy|January 1, 1986
Beta-lactamases with high activity against imipenem and Sch 34343 from Aeromonas hydrophilaK Shannon, A King, I PhillipsThe Journal of Antimicrobial Chemotherapy|May 1, 1985
The in-vitro activities of enoxacin and ofloxacin compared with that of ciprofloxacinA King, K Shannon, I PhillipsAntimicrobial Agents and Chemotherapy|February 1, 1980
In vitro antibacterial activity and susceptibility of cefsulodin, an antipseudomonal cephalosporin, to beta-lactamasesA King, K Shannon, I PhillipsThe American Journal of Medicine|June 30, 1986
Prevalence and mechanisms of aminoglycoside resistance. A ten-year studyI Phillips, A King, K ShannonThe Journal of Antimicrobial Chemotherapy|December 1, 1995
Resistance to imipenem in Pseudomonas aeruginosaA King, K Shannon, I PhillipsThe Journal of Antimicrobial Chemotherapy|June 1, 1985
Sch 34343: in-vitro antibacterial activity and susceptibility to beta-lactamasesK Shannon, A King, I PhillipsThe Journal of Antimicrobial Chemotherapy|April 1, 1984
The in-vitro activity of ciprofloxacin compared with that of norfloxacin and nalidixic acidA King, K Shannon, I PhillipsAntimicrobial Agents and Chemotherapy|April 1, 1982
In vitro antibacterial activity of norfloxacin (MK-0366)A King, C Warren, K Shannon, et al.Pageof 976